Cc1c(NC(=O)c2ccccc2N(C)S(=O)(=O)c2ccccc2)c(=O)n(-c2ccccc2)n1C
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?